MIRA INFORM REPORT

 

 

Report Date :           

10.01.2012

 

IDENTIFICATION DETAILS

 

Name :

INTER  PHARMAPLUS  CO.,  LTD.

 

 

Registered Office :

9  Soi  Serithai  81/2,  Serithai  Road, Kannayao,  Bangkok  10230

 

 

Country :

Thailand

 

 

Financials (as on) :

30.04.2011

 

 

Date of Incorporation :

11.05.2004

 

 

Com. Reg. No.:

0105547063800

 

 

Legal Form :

Private  Limited  Company

 

 

Line of Business :

Importer  and  distributor of hard  gelatin  capsules

 

 

No. of Employees :

12

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – September 30th, 2011

 

Country Name

Previous Rating

                   (30.06.2011)                  

Current Rating

(30.09.2011)

Thailand

b1

b1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

Company name

 

INTER  PHARMAPLUS  CO.,  LTD.

 

 

SUMMARY

 

BUSINESS  ADDRESS                          :           9  SOI  SERITHAI  81/2,  SERITHAI  ROAD, 

                                                                        KANNAYAO,  BANGKOK  10230,  THAILAND

TELEPHONE                                         :           [66]  2919-9429-30,  2919-8303,  089  202-9512 

FAX                                                      :           [66]  2906-0244

E-MAIL  ADDRESS                                :           pharma@inter-pharmaplus.com

REGISTRATION  ADDRESS                   :           SAME  AS  BUSINESS  ADDRESS

ESTABLISHED                                     :           2004

REGISTRATION  NO.                            :           0105547063800  [Former  :  0108554706931]

CAPITAL REGISTERED                         :           BHT.  10,000,000 

CAPITAL PAID-UP                                 :           BHT.  10,000,000 

SHAREHOLDER’S  PROPORTION         :           THAI     :    100%

FISCAL YEAR CLOSING DATE              :           APRIL  30          

LEGAL  STATUS                                   :           PRIVATE  LIMITED  COMPANY

EXECUTIVE                                          :           MS. NATTHANAREE  DAENGVICHIT,  THAI

                                                                        MANAGING  DIRECTOR           

NO.  OF  STAFF                                    :           12

LINES  OF  BUSINESS                          :           HARD  GELATIN  CAPSULES

                                                                        IMPORTER  AND  DISTRIBUTOR

                                                                         

                                                                         

CORPORATE PROFILE

 

OPERATING  TREND                             :           STABLE                       

PRESENT  SITUATION                          :           OPERATING  NORMALLY                     

REPUTATION                                        :           GOOD  WITH  NORMAL  BUSINESS  ENGAGEMENT

MANAGEMENT  STANDARD                 :           MANAGEMENT  WITH  FAIR  PERFORMANCE             

 

 

 

 

 

 

 


HISTORY

 

The  subject  was  established  on  May  11,  2004  as  a  private  limited  company  under  the   name  style INTER PHARMAPLUS  CO., LTD.,  by  Thai   group,  Trangkanont  family,   in  order  to  import  and  distribute  hard  gelatin  capsule  products.  It  currently  employs  12   staff.  

 

The subject’s  registered  address was initially at 170/4 Moo 3, Soi  Serithai  1, Serithai Rd.,  Kannayao,  Bangkok  10230.

 

On  November  3,  2006,   the  registered  address  was  changed  from “170/4 Moo 3, Soi  Serithai  1”  to  “9 Soi  Serithai  81/2”  by  the  Government  district office,  actually both  are  the  same  location.  This  is  also  the  subject’s  current  operation  address.

 

 

THE BOARD OF DIRECTORS

 

     Name

 

Nationality

Age

 

 

 

 

Ms. Natthanaree  Daengvichit

 

Thai

38

Ms. Lakhana  Trangkanont

 

Thai

43

 

 

AUTHORIZED PERSON

 

One  of  the   above  directors  can   sign  on  behalf  of  the  subject  with  company’s  affixed.

 

 

MANAGEMENT

 

Ms. Natthanaree  Daengvichit  is  the  Managing  Director.

She  is  Thai  nationality  with  the  age  of  38  years  old.  

 

 

BUSINESS OPERATIONS

 

The subject is engaged in importing and distributing hard gelatin capsules  for  pharmaceutical,  herbal  and  additive  food  production  industries.

 

IMPORT  

Most  of  the  products  are  imported  from  India.

 

MAJOR  SUPPLIER

Healthcaps  India  Ltd.    :    India

 


SALES 

100%  of  the  products  is  sold  locally  by  wholesale  to  dealers  and  manufacturers.

 

MAJOR  CUSTOMER

The  Government  Pharmaceutical  Organization

 

SUBSIDIARY  AND  AFFILIATED  COMPANY

The  subject  is  not  found  to  have  any  subsidiary  or  affiliated  company  here  in  Thailand.

 

LITIGATION

 

Bankruptcy  and  Receivership

There  are  no  litigation  on  bankruptcy  and  receivership  cases  filed  against  the  subject  found  at  Legal  Execution  Department  for  the  past  five  years.

 

Others

There  are  no  legal  suits  filed  against   the  subject  for  the  past  two  years.

 

CREDIT  

Sales  are  by  cash  or  on  the  credits  term  of  30-60  days.

Local  bills  are  paid  by  cash  or  on  the  credits  term  of  30-60  days.

Imports  are  by  L/C  at  sight  or  T/T.

 

BANKING

Bangkok  Bank  Public  Co., Ltd.

 [Klongchan  Branch :  Serithai  Rd.,   Klongchan,  Bangkapi,  Bangkok]

 

EMPLOYMENT

The  subject  employs  12  staff.  [office  and  sales staff]

 

LOCATION  DETAILS

The  premise  is  owned  for  administrative  office  at  the  heading  address.  Premise  is  located  in  commercial/residential  area.

 

REMARK

MAXIMUM  CREDIT  SHOULD  BE  GRANTED  AT  US$  500,000. 

 

COMMENT

Despite  Thai  manufactures  can  produce  hard  gelatin  capsule,  but  it  is  not  enough  for  strong  demand  of  pharmaceutical,  herb medicine  and  supplement  products  industries. 

 

The  products  which  has  been  imported  and  distributed  by  subject  has   strongly  grown  in  line  with  demand  from  local  industries.

 

 

FINANCIAL INFORMATION

 

The  capital  was  initially  registered  at  Bht. 1,000,000  divided  into  10,000  shares  of  Bht.   100  each.

 

The  capital  was  increased  later  as  follows:

 

            Bht.    3,000,000  on  May  26,  2005

            Bht.  10,000,000  on  July  13,  2009

 

The  latest  registered  capital  was  increased to  Bht. 10,000,000  divided  into  100,000  shares  of  Bht.  100   each  with  fully  paid.

 

THE  SHAREHOLDERS  LISTED  WERE  :  [as  at  August  30,  2011]

       NAME

HOLDING

%

 

 

 

Ms. Natthanaree  Daengvichit

Nationality:  Thai

Address     :  405/1  Moo  12,  Serithai   Rd.,  Kannayao, 

                     Bangkok

82,999

83.00

Ms. Lakhana  Trangkanont

Nationality:  Thai

Address     :  144  Suansayam  Rd.,  Kannayao,  Bangkok 

  17,000

17.00

Ms. Amphan  Trangkanont

Nationality:  Thai

Address     :  261  Moo 5,  Thakham,  Palian,  Trang

          1

-

 

Total  Shareholders  :  3

 

Share  Structure  [as  at  August  30,  2011]

Nationality

Shareholders

No. of  Share

% Shares

 

 

 

 

Thai

3

100,000

100.00

Foreign

-

-

-

 

Total

 

3

 

100,000

 

100.00

 

NAME  OF  AUDIOTOR & CERTIFIED  PUBLIC  ACCOUNTANT  NO.  

Ms. Vimol  Pinthupeerakovit  No.  6009

 

 


BALANCE SHEET [BAHT]

 

The  latest  financial figures  published  as  at  April  30,  2011  &  2010  were:

          

ASSETS

                                                                                                

Current Assets

2011

2010

 

 

 

Cash  and Cash Equivalents     

16,043,680.16

12,222,046.20

Trade  Accounts  Receivable 

28,014,524.03

20,095,999.54

Inventories     

8,088,019.56

15,356,034.31

Other  Current  Assets                  

2,372,150.27

1,717,388.15

 

 

 

Total  Current  Assets                

54,518,374.02

49,391,468.20

 

Long-term Loan to Related Person

 

-

 

-

Fixed Assets

2,168,694.08

3,134,658.96

Cash  at Bank Pledged  as  a  Collateral

2,117,247.88

2,098,722.67

 

Total  Assets                 

 

58,804,315.98

 

54,624,849.83

 

 

LIABILITIES & SHAREHOLDERS’ EQUITY [BAHT]

 

Current Liabilities

2011

2010

 

 

 

Bank Overdraft   from  Financial Institutions

1,614,256.59

1,045,497.81

Trade  Accounts   Payable    

36,039,865.21

28,767,331.56

Current  Portion  of  Long-term

   Hire-purchase  Contract Liabilities

 

625,559.55

 

809,763.34

Current  Portion  of  Long-term Loans

   from  Financial Institutions

 

3,285,479.90

 

3,701,626.26

Other  Current  Liabilities             

363,065.65

116,571.58

 

 

 

Total Current Liabilities

41,928,226.90

34,440,790.55

 

Long-term  Hire-purchase  Contract

    Liabilities,  net

 

 

154,117.70

 

 

721,238.45

Long-term Loan from  Financial Institutions

2,776,322.12

6,044,923.96

 

Total  Liabilities            

 

44,858,666.72

 

41,206,952.96

 

 

 

Shareholders' Equity

 

 

 

 

 

Share  capital : Baht  100  par  value 

  authorized,  issued  and  fully 

  paid  share  capital  100,000  shares 

 

 

10,000,000.00

 

 

10,000,000.00

 

 

 

Capital  Paid                      

10,000,000.00

10,000,000.00

Retained Earning-Unappropriated                    

3,945,649.26

3,417,896.87

 

Total Shareholders' Equity

 

13,945,649.26

 

13,417,896.87

 

Total Liabilities &  Shareholders'  Equity

 

58,804,315.98

 

54,624,849.83

 

                                                  

PROFIT & LOSS ACCOUNT

 

Revenue

2011

2010

 

 

 

Sales  Income

144,322,545.72

130,986,333.27

Gain on Exchange Rate

-

-

Other  Income                 

4,495,130.04

2,688,593.57

 

Total  Revenues           

 

148,817,675.76

 

133,674,926.84

 

Expenses

 

 

 

 

 

Cost  of  Goods  Sold 

139,346,240.73

125,187,596.90

Selling  Expenses

639,077.93

479,702.50

Administrative  Expenses

6,656,376.51

5,699,866.07

 

Total Expenses             

 

146,641,695.17

 

131,367,165.47

 

 

 

Profit  before  Financial Cost  &   Income  Tax

2,175,980.59

2,307,761.37

Financial Costs

[1,384,035.62]

[1,366,956.12]

 

Profit  before Income Tax

 

791,944.97

 

940,805.25

Income Tax

[264,192.58]

[292,201.75]

 

 

 

Net  Profit / [Loss]

527,752.39

648,603.50

 

 

 


FINANCIAL ANALYSIS

 

ITEM

UNIT

2011

2010

 

 

 

 

LIQUIDITY RATIO

 

 

 

CURRENT RATIO

TIMES

1.30

1.43

QUICK RATIO

TIMES

1.05

0.94

 

 

 

 

ACTIVITY RATIO

 

 

 

FIXED ASSETS TURNOVER

TIMES

66.55

41.79

TOTAL ASSETS TURNOVER

TIMES

2.45

2.40

INVENTORY CONVERSION PERIOD

DAYS

21.19

44.77

INVENTORY TURNOVER

TIMES

17.23

8.15

RECEIVABLES CONVERSION PERIOD

DAYS

70.85

56.00

RECEIVABLES TURNOVER

TIMES

5.15

6.52

PAYABLES CONVERSION PERIOD

DAYS

94.40

83.87

CASH CONVERSION CYCLE

DAYS

(2.37)

16.90

 

 

 

 

PROFITABILITY RATIO

 

 

 

COST OF GOODS SOLD

%

96.55

95.57

SELLING & ADMINISTRATION

%

5.05

4.72

INTEREST

%

0.96

1.04

GROSS PROFIT MARGIN

%

6.56

6.48

NET PROFIT MARGIN BEFORE EX. ITEM

%

1.51

1.76

NET PROFIT MARGIN

%

0.37

0.50

RETURN ON EQUITY

%

3.78

4.83

RETURN ON ASSET

%

0.90

1.19

EARNING PER SHARE

BAHT

5.28

6.49

 

 

 

 

LEVERAGE RATIO

 

 

 

DEBT RATIO

TIMES

0.76

0.75

DEBT TO EQUITY RATIO

TIMES

3.22

3.07

TIME INTEREST EARNED

TIMES

1.57

1.69

 

 

 

 

ANNUAL GROWTH

 

 

 

SALES GROWTH

%

10.18

 

OPERATING PROFIT

%

(5.71)

 

NET PROFIT

%

(18.63)

 

FIXED ASSETS

%

(30.82)

 

TOTAL ASSETS

%

7.65

 

 


 

 

 

PROFITABILITY RATIO

 

Gross Profit Margin

6.56

Deteriorated

Industrial Average

31.85

Net Profit Margin

0.37

Impressive

Industrial Average

(8.20)

Return on Assets

0.90

Impressive

Industrial Average

(0.68)

Return on Equity

3.78

Acceptable

Industrial Average

6.86

 

Gross Profit Margin used to assess a firm's financial health by revealing the proportion of money left over from revenues after accounting for the cost of goods sold. Gross profit margin serves as the source for paying additional expenses and future savings. The company's figure is 6.56%. When compared with the industry average, the ratio of the company was lower. This  indicated that company was originated from the problems with control over its costs.

 

Net Profit Margin is the indicator of the company's efficiency in that net profit takes into consideration all expenses of the company. A low profit margin indicates a low margin of safety, higher risk that a decline in sales will erase profits and result in a net loss. Net Profit Margin ratio is 0.37%, higher figure when compared with those of its average competitors in the same industry, indicated that business was an efficient operator in a dominant position within its industry.

 

Return on Assets measures how efficiently profits are being generated from the assets employed in the business when compared with the ratios of firms in a similar business. A low ratio in comparison with industry averages indicates an inefficient use of business assets. Return on Assets ratio is 0.9%, higher figure when compared with those of its average competitors in the same industry, indicated that business was an efficient profit in a dominant position within its industry.

 

Return on Equity indicates how profitable a company is by comparing its net income to its average shareholders' equity, ROE measures how much the shareholders earned for their investment in the company. When compared with the industry average, it was lower, the company's figure is 3.78%.

 

Trend of the average competitors in the same industry for last 5 years

Return on Assets                       Downtrend

Return on Equity                        Downtrend

 

 

 

LIQUIDITY RATIO

 

Current Ratio

1.30

Deteriorated

Industrial Average

23.11

Quick Ratio

1.05

 

 

 

Cash Conversion Cycle

(2.37)

 

 

 

 

The Current Ratio is to ascertain whether a company's short-term assets are readily available to pay off its short-term liabilities. The company's figure is 1.3 times in 2011, decrease from 1.43 times, then it is generally considered to have good short-term financial strength. When compared with the industry average, the ratio of the company was lower.

 

The Quick Ratio is a liquidity indicator that further refines the current ratio by measuring the amount of the most liquid current assets there are to cover current liabilities. The company's figure is 1.05 times in 2011, increase from 0.94 times, although excluding inventory so the company still have good short-term financial strength.

 


 

The Cash Conversion Cycle measures the number of days a company's cash is tied up in the production and sales process of its operations and the benefit from payment terms from its creditors. It meant the company could survive when no cash inflow was received from sale for -3 days.

 

Trend of the average competitors in the same industry for last 5 years

Current Ratio                 Uptrend

 

 


 

LEVERAGE RATIO

 

Debt Ratio

0.76

Impressive

Industrial Average

1.03

Debt to Equity Ratio

3.22

Risky

Industrial Average

1.27

Times Interest Earned

1.57

Deteriorated

Industrial Average

219.42

 

Debt to Equity Ratio a measurement of how much suppliers, lenders, creditors and obligors have committed to the company versus what the shareholders have committed. A lower the percentage means that the company is using less leverage and has a stronger equity position.

 

Times Interest Earned measuring a company's ability to meet its debt obligations. Ratio is 1.58 higher than 1, so the company can pay interest expenses on outstanding debt.

 

Debt Ratio shows the proportion of a company's assets which are financed through debt. The company's figure is 0.76 greater than 0.5, most of the company's assets are financed through debt.

 

Trend of the average competitors in the same industry for last 5 years

Debt Ratio                                 Uptrend

Times Interest Earned                Uptrend

 


ACTIVITY RATIO

 

Fixed Assets Turnover

66.55

Deteriorated

Industrial Average

9,574.74

Total Assets Turnover

2.45

Impressive

Industrial Average

1.77

Inventory Conversion Period

21.19

 

 

 

Inventory Turnover

17.23

Impressive

Industrial Average

12.28

Receivables Conversion Period

70.85

 

 

 

Receivables Turnover

5.15

Deteriorated

Industrial Average

13.02

Payables Conversion Period

94.40

 

 

 

 

Trend of the average competitors in the same industry for last 5 years

Fixed Assets Turnover                Uptrend

Total Assets Turnover                 Downtrend

Inventory Turnover                      Uptrend

Receivables Turnover                  Uptrend

 

 

 

 


FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.52.73

UK Pound

1

Rs.81.34

Euro

1

Rs.67.01

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.